Unique features of central neuropathic pain in multiple sclerosis: Results of a cluster analysis

被引:11
|
作者
Rivel, Michal [1 ,2 ]
Achiron, Anat [2 ,3 ,4 ]
Dolev, Mark [3 ]
Stern, Yael [3 ]
Zeilig, Gabi [4 ,5 ]
Defrin, Ruth [1 ,2 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel
[2] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[3] Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[5] Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel
关键词
QUALITY-OF-LIFE; CENTRAL SENSITIZATION; OFFSET ANALGESIA; PREVALENCE; MODULATION; MECHANISMS; QUESTIONNAIRE; METAANALYSIS; SEVERITY;
D O I
10.1002/ejp.1934
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background Central neuropathic pain (CNP) is an excruciating condition, prevalent in up to a third of patients with multiple sclerosis (MS). Identifying CNP among MS patients is particularly challenging considering the ample comorbid chronic pain conditions and sensory disturbances entailed by the disease. The aim was to identify sensory features unique to CNP beyond those of chronic pain and MS. Methods Participants were 112 MS patients: 44 with a diagnosis of CNP, 28 with a diagnosis of chronic musculoskeletal pain (MSP), and 40 pain free. Participants underwent testing of thermal and mechanical thresholds, thermal grill illusion (TGI), pain adaptation (PA), and offset analgesia (OA), and chronic pain was characterized. A two-step cluster analysis was performed, and the association between the cluster membership and the clinical group membership (CNP, MSP, pain free) was evaluated. Results The CNP and MSP groups were similar in most of the chronic pain variables (e.g., severity, location and quality) and MS-related variables (e.g., type, severity and medication intake). The three created clusters had unique sensory features: (1) 'Hyposensitivity' (increased thermal and touch thresholds) characterized the CNP group; (2) 'Poor inhibition and hyperalgesia' (worst PA and OA and decreased TGI threshold) characterized the MSP group; and (3) 'Efficient inhibition' (best PA and OA, smallest sensory loss) characterized the pain-free group. Conclusions The unique sensory features of CNP and MSP provide insight into their pathophysiology, and evaluating them may increase the ability to provide individually based interventions. Efficient inhibition may protect MS patients from chronic pain. Significance Cluster analysis among patients with multiple sclerosis (MS) revealed that while central neuropathic pain is associated with thermal and mechanical hypoesthesia, musculoskeletal pain is involved with reduced pain inhibition and hyperalgesia; sensory profiles that provide insights into the mechanisms of these conditions and may promote an individually based pain management.
引用
收藏
页码:1107 / 1122
页数:16
相关论文
共 50 条
  • [1] Efficacy results of a study of THC:CBD in central neuropathic pain due to multiple sclerosis
    Ratcliffe, Stuart
    Metz, Luanne M.
    Ambler, Zdenek
    MULTIPLE SCLEROSIS, 2008, 14 : S158 - S158
  • [2] Neuropathic pain in multiple sclerosis
    Young, C. A.
    Mills, R. J.
    Tennant, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 130 - 130
  • [3] Central Neuropathic Pain and Profiles of Quantitative Electroencephalography in Multiple Sclerosis Patients
    Krupina, Nataliya A.
    Churyukanov, Maxim, V
    Kukushkin, Mikhail L.
    Yakhno, Nikolay N.
    FRONTIERS IN NEUROLOGY, 2020, 10
  • [4] Sensory and pain modulation profiles of ongoing central neuropathic extremity pain in multiple sclerosis
    Srotova, Iva
    Kocica, Jan
    Vollert, Jan
    Kolcava, Jan
    Hulova, Monika
    Jarkovsky, Jiri
    Dusek, Ladislav
    Bednarik, Josef
    Vlckova, Eva
    EUROPEAN JOURNAL OF PAIN, 2021, 25 (03) : 573 - 594
  • [5] Sensory and pain modulation profiles of central neuropathic ongoing extremity pain in multiple sclerosis
    Bednarik, J.
    Srotova, I.
    Vlckova, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [6] MULTIPLE SCLEROSIS INDUCED NEUROPATHIC PAIN
    Begum, F.
    Madec, K.
    Namaka, M.
    Frost, E.
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 : 76 - 77
  • [7] Mediating Neuropathic Pain In Multiple Sclerosis
    Lamerand, Sydney R.
    Deshpande, Ronit
    Anumolu, Anvita
    Taylor, Bradley K.
    JOURNAL OF PAIN, 2023, 24 (04): : 42 - 42
  • [8] THE THALAMUS AND NEUROPATHIC PAIN IN MULTIPLE SCLEROSIS
    Seixas, D.
    Palace, J.
    Jbabdi, S.
    Miller, K.
    MacIntosh, B.
    Donahue, M.
    Deoni, S.
    Kolind, S.
    Weir, A.
    Tracey, I.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [9] Duloxetine for neuropathic pain in multiple sclerosis
    Vollmer TL
    Robinson MJ
    Risser RC
    中华物理医学与康复杂志, 2015, (01) : 78 - 78
  • [10] Neuropathic Pain in Multiple Sclerosis Patients
    Spirin N.N.
    Kiselev D.V.
    Karpova M.S.
    Neuroscience and Behavioral Physiology, 2022, 52 (4) : 477 - 485